Endo End® Dienogest 2 mg – Targeted Endometriosis Relief

A targeted, low-dose continuous oral therapy, Endo End harnesses the proven efficacy of Dienogest to bring you best-in-class management of endometriosis and related gynecological conditions. Meticulously formulated by Health Care Pharmaceuticals, Endo End is designed to not only relieve pain but also to slow disease progression and help preserve future fertility—providing comprehensive support for women at every stage of their reproductive health journey.

Composition & Mechanism of Action

Each film-coated tablet contains Dienogest 2 mg, a synthetic progestogen with high selectivity for the progesterone receptor and minimal androgenic activity. By suppressing estrogen-driven proliferation of ectopic endometrial tissue, Dienogest effectively:

• Reduces pelvic inflammation and pain

• Inhibits growth of endometriotic implants

• Stabilizes ectopic lesions

• Improves menstrual regularity

This targeted action helps restore hormonal balance, alleviate distressing symptoms, and support long-term disease control.

Clinical Indications

Endo End® is indicated for:

• Endometriosis

  • Relief of associated pelvic pain

  • Management of extragenital lesions (e.g., bladder, colon)

  • Treatment of small ovarian cysts and endometriomas

• Adenomyosis

  • Control of heavy menstrual bleeding and dysmenorrhea

• Secondary Dysmenorrhea

  • Alleviation of recurrent menstrual pain not resolved by NSAIDs

• Pre- and Post-operative Therapy

  • Hormonal preparation before surgery and to reduce recurrence risk

Did you know? Up to 73% of adolescents with severe primary dysmenorrhea are later diagnosed with endometriosis—early intervention with Dienogest can be pivotal in preventing disease progression.

Key Benefits

• Effective Pain Relief: Rapid reduction in dysmenorrhea and chronic pelvic pain

• Disease Control: Suppression of lesion growth and reduced recurrence post-surgery

• Fertility Preservation: Maintains ovarian reserve and hormonal milieu conducive to conception

• Convenient Regimen: Once-daily dosing supports adherence and quality of life

• Long-Term Safety: Extensive data support safe use for up to five years